SAGE Short Information, Sage Therapeutics Inc.

Twenty Trading Day Totals
Total Shorted Volume	2,183,831
Total Actual Volume	24,948,834

Averages
Average Short Volume	109,192
Average Short Percentage	42.38%

Is there a SAGE Short Squeeze or Breakout about to happen?

See the SAGE Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2022-06-29	32.25	32.81	32.9	31.77	417,715	50,045	60.1278
2022-06-28	34.93	32.54	35.58	32.48	639,128	52,316	34.8251
2022-06-27	33.97	34.93	35.08	33.5	1,163,564	101,831	34.0316
2022-06-24	35.98	33.65	36.19	33.6	8,111,281	276,869	54.7418
2022-06-23	35.5	35.48	35.8	33.5	1,298,323	96,573	19.7258
2022-06-22	33.25	35.47	36.055	33.06	790,259	52,599	27.4743
2022-06-21	34.81	34.15	35.3275	33.62	945,901	88,946	38.0899
2022-06-16	31.69	31.36	31.855	30.665	916,162	101,783	40.4878
2022-06-15	32.02	32.57	33.1	31.62	842,161	180,729	60.4105
2022-06-14	32.19	31.87	32.81	31.51	758,842	110,109	49.5504
2022-06-13	33.61	32	34	31.73	1,522,261	142,059	34.2388
2022-06-09	37.1	37.29	37.66	36.5	771,329	51,952	26.1040
2022-06-08	36.61	37.53	37.62	36.33	650,714	73,698	37.9714
2022-06-06	37.79	36.88	38.16	36.785	1,091,306	151,508	44.4832
2022-06-03	36.47	36.93	37.27	35.9	996,457	95,172	35.2667
2022-06-02	34.2	36.71	36.785	33.56	1,085,536	148,124	38.2168
2022-06-01	31.63	34.24	34.81	31.63	1,480,837	224,626	39.0570
2022-05-31	31.95	31.27	32.33	30.71	740,562	104,015	61.2116
2022-05-26	31.85	31.93	32.86	31.84	332,014	32,672	51.5591
2022-05-25	31.98	31.67	32.36	31.16	394,482	48,205	59.9900

Stock Information

Sage Therapeutics Inc. Company Name:

SAGE Stock Symbol:

NASDAQ Market:

Sage Therapeutics Inc. Website:

SAGE Short Information, Sage Therapeutics Inc.

Get SAGE Alerts

News, Short Squeeze, Breakout and More Instantly...

SAGE - Why Shares of Sage Therapeutics Climbed 15.6% This Week

Shares of Sage Therapeutics (NASDAQ: SAGE) , a biopharmaceutical company that specializes in brain disorder therapies, saw its shares rise 15.6% this week, according to data from S&P Global Market Intelligence . The stock closed last Friday at $32.24 but rose to $37.27 this ...
SAGE - Sage Therapeutics to Present at Upcoming June Investor Conferences

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in June: Jefferies Healthcare Conference (New York, NY): fir...
SAGE - Sage Therapeutics and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression Met its Primary and All Key Secondary Endpoints

Zuranolone 50 mg demonstrated a statistically significant and clinically meaningful improvement in depressive symptoms at Day 15, the primary endpoint, and at Days 3, 28, and 45, key secondary endpoints Zuranolone 50 mg was generally well-tolerated and demonstrated a safety pr...